correspondence
Response to the ACMD's report on remimazolam (Byfavo)
Published 2023-03-02.
The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the classification and schedule of remimazolam (Byfavo).
§ Publishing organisations